Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma

IF 1.6 4区 医学 Q4 IMMUNOLOGY
Chiyu He , Wei Shen , Zuyuan Lin , Zhihang Hu , Huigang Li , Hao Chen , Modan Yang , Xinyu Yang , Jianyong Zhuo , Linhui Pan , Xuyong Wei , Li Zhuang , Shusen Zheng , Di Lu , Xiao Xu
{"title":"Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma","authors":"Chiyu He ,&nbsp;Wei Shen ,&nbsp;Zuyuan Lin ,&nbsp;Zhihang Hu ,&nbsp;Huigang Li ,&nbsp;Hao Chen ,&nbsp;Modan Yang ,&nbsp;Xinyu Yang ,&nbsp;Jianyong Zhuo ,&nbsp;Linhui Pan ,&nbsp;Xuyong Wei ,&nbsp;Li Zhuang ,&nbsp;Shusen Zheng ,&nbsp;Di Lu ,&nbsp;Xiao Xu","doi":"10.1016/j.trim.2024.102071","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>To improve liver organ allocation, the model for end-stage liver disease (MELD) score was adopted in candidates reflecting the severity of liver disease and the physical condition of patients. Inflammatory markers are prognostic factors for various cancers and play prognostic roles in patients after liver transplantation (LT) for hepatocellular carcinoma (HCC). Researchers focused more on pre-LT inflammatory markers, while the role of dynamic change of these inflammatory markers is still unknown. The purpose of this study was to estimate the prognostic value of pre-LT and post-LT inflammatory markers.</p></div><div><h3>Material and methods</h3><p>We collected the pre-LT complete blood count and the post-LT result with highest count of white blood cells within 48 h. Platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and systemic immune-inflammation index were calculated, and their prognostic roles were analyzed for their MELD scores.</p></div><div><h3>Results</h3><p>This retrospective two-center cohort study enrolled 290 patients after LT for HCC. Multivariate analysis identified pre-LT PLR as independent risk factor for recurrence-free survival (RFS) [HR (95%CI): 1.002 (1.000–1.003), <em>p</em> = 0.023]. A high pre-LT PLR or post-LT PLR were associated with poorer RFS (<em>p</em> &lt; 0.001 and <em>p</em> = 0.004, respectively). Based on the MELD scores, the pre-LT PLR value was able to predict the RFS in high MELD group (p &lt; 0.001) but had no predictive power in low MELD group (<em>p</em> = 0.076). On the contrary, the post-LT PLR value was better to predict the overall RFS value in low MELD group (<em>p</em> = 0.007) but could not predict the overall RFS value in high MELD group (<em>p</em> = 0.136).</p></div><div><h3>Conclusions</h3><p>Both pre-LT PLR and post-LT PLR demonstrated prognostic value in patients following LT for HCC. Monitoring PLR values based on the MELD score can improve the predictive prognosis and more effectively guide the individual decisions for the postoperative intervention.</p></div>","PeriodicalId":23304,"journal":{"name":"Transplant immunology","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S096632742400087X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

To improve liver organ allocation, the model for end-stage liver disease (MELD) score was adopted in candidates reflecting the severity of liver disease and the physical condition of patients. Inflammatory markers are prognostic factors for various cancers and play prognostic roles in patients after liver transplantation (LT) for hepatocellular carcinoma (HCC). Researchers focused more on pre-LT inflammatory markers, while the role of dynamic change of these inflammatory markers is still unknown. The purpose of this study was to estimate the prognostic value of pre-LT and post-LT inflammatory markers.

Material and methods

We collected the pre-LT complete blood count and the post-LT result with highest count of white blood cells within 48 h. Platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and systemic immune-inflammation index were calculated, and their prognostic roles were analyzed for their MELD scores.

Results

This retrospective two-center cohort study enrolled 290 patients after LT for HCC. Multivariate analysis identified pre-LT PLR as independent risk factor for recurrence-free survival (RFS) [HR (95%CI): 1.002 (1.000–1.003), p = 0.023]. A high pre-LT PLR or post-LT PLR were associated with poorer RFS (p < 0.001 and p = 0.004, respectively). Based on the MELD scores, the pre-LT PLR value was able to predict the RFS in high MELD group (p < 0.001) but had no predictive power in low MELD group (p = 0.076). On the contrary, the post-LT PLR value was better to predict the overall RFS value in low MELD group (p = 0.007) but could not predict the overall RFS value in high MELD group (p = 0.136).

Conclusions

Both pre-LT PLR and post-LT PLR demonstrated prognostic value in patients following LT for HCC. Monitoring PLR values based on the MELD score can improve the predictive prognosis and more effectively guide the individual decisions for the postoperative intervention.

肝细胞癌肝移植术后血小板与淋巴细胞比值对终末期肝病预后能力的影响模型。
背景:为改善肝脏器官分配,末期肝病模型(MELD)评分被采用于反映肝病严重程度和患者身体状况的候选者中。炎症标志物是各种癌症的预后因素,在肝细胞癌(HCC)肝移植(LT)后的患者中发挥着预后作用。研究人员更关注肝移植前的炎症标志物,而这些炎症标志物的动态变化的作用尚不清楚。本研究的目的是估计肝移植前和肝移植后炎症标志物的预后价值:我们收集了 LT 前的全血细胞计数和 48 小时内白细胞计数最高的 LT 后结果。计算血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值和全身免疫炎症指数,并分析其对 MELD 评分的预后作用:这项回顾性双中心队列研究共纳入了290名接受LT治疗的HCC患者。多变量分析发现,LT前PLR是无复发生存期(RFS)的独立危险因素[HR(95%CI):1.002 (1.000-1.003),p = 0.023]。LT前PLR高或LT后PLR高与较差的RFS相关(p 结论:LT前PLR和LT后PLR均与较差的RFS相关:LT前PLR和LT后PLR对HCC患者的预后均有价值。根据 MELD 评分监测 PLR 值可改善预后预测,更有效地指导术后干预的个体决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transplant immunology
Transplant immunology 医学-免疫学
CiteScore
2.10
自引率
13.30%
发文量
198
审稿时长
48 days
期刊介绍: Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses. The journal will be directed at (basic) scientists, tissue typers, transplant physicians and surgeons, and research and data on all immunological aspects of organ-, tissue- and (haematopoietic) stem cell transplantation are of potential interest to the readers of Transplant Immunology. Original papers, Review articles and Hypotheses will be considered for publication and submitted manuscripts will be rapidly peer-reviewed and published. They will be judged on the basis of scientific merit, originality, timeliness and quality.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信